Country Club Trust’s AstraZeneca AZN Stock Holding History

Country Club Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,960	Closed	-$206K	–	255
2017 Q4	$206K	Sell	2,960 -119	-4%	-$8.03K	0.03%	206
2017 Q3	$209K	Buy	+3,079	New	+$195K	0.03%	207
2014 Q4	–	Sell	-3,656	Closed	-$261K	–	222
2014 Q3	$261K	Hold	3,656	–	–	0.03%	195
2014 Q2	$272K	Sell	3,656 -10,475	-74%	-$757K	0.04%	198
2014 Q1	$917K	Sell	14,131 -134,328	-90%	-$8.68M	0.13%	144
2013 Q4	$8.81M	Buy	148,459 +2,981	+2%	+$162K	1.29%	18
2013 Q3	$7.55M	Buy	145,478 +5,170	+4%	+$260K	1.2%	19
2013 Q2	$6.64M	Buy	+140,308	New	+$7.14M	1.12%	18

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Country Club Trust's AZN Position: Q1 2018 in Review

Country Club Trust sold out of AstraZeneca (AZN) in Q1 2018, closing a stake of 2,960 shares — an estimated $206K sold.

Country Club Trust first reported a position in AZN in Q2 2013 and held it in 8 quarters. The position peaked at $8.81M in Q4 2013. 519 funds tracked by Wall St. Rank hold AZN as of Q1 2018.

Country Club Trust reported no remaining AstraZeneca position as of Q1 2018 after selling out during the quarter.
Country Club Trust sold 2,960 AstraZeneca shares in Q1 2018, an estimated $206K.
Country Club Trust first reported a position in AstraZeneca in Q2 2013 and held it in 8 quarters.
Country Club Trust's AstraZeneca position peaked at $8.81M in Q4 2013.
519 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2018.

Based on Country Club Trust's 13F filing for Q1 2018, filed 11 Apr 2018.